Literature DB >> 23650613

Developmental expression of IL-12Rβ2 on murine naive neonatal T cells counters the upregulation of IL-13Rα1 on primary Th1 cells and balances immunity in the newborn.

Christine M Hoeman1, Mermagya Dhakal, Adam A Zaghouani, Jason A Cascio, Xiaoxiao Wan, Marie-Therese Khairallah, Weirong Chen, Habib Zaghouani.   

Abstract

Upon exposure to Ag on the day of birth, neonatal mice mount balanced primary Th1 and Th2 responses, with the former displaying upregulated IL-13Rα1 expression. This chain associates with IL-4Rα to form a heteroreceptor (IL-4Rα/IL-13Rα1) that marks the Th1 cells for death by IL-4 produced by Th2 cells during rechallenge with Ag, hence the Th2 bias of murine neonatal immunity. The upregulation of IL-13Rα1 on neonatal Th1 cells was due to the paucity of IL-12 in the neonatal environment. In this study, we show that by day 8 after birth, naive splenic T cells are no longer susceptible to IL-13Rα1 upregulation even when exposed to Ag within the neonatal environment. Furthermore, during the 8-d lapse, the naive splenic T cells spontaneously and progressively upregulate the IL-12Rβ2 chain, perhaps due to colonization by commensals, which induce production of IL-12 by cells of the innate immune system such as dendritic cells. In fact, mature T cells from the thymus, a sterile environment not accessible to microbes, did not upregulate IL-12Rβ2 and were unable to counter IL-13Rα1 upregulation. Finally, the 8-d naive T cells were able to differentiate into Th1 cells even independently of IL-12 but required the cytokine to counter upregulation of IL-13Rα1. Thus, in neonatal mice, IL-12, which accumulates in the environment progressively, uses IL-12Rβ2 to counter IL-13Rα1 expression in addition to promoting Th1 differentiation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23650613      PMCID: PMC3679234          DOI: 10.4049/jimmunol.1202207

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation.

Authors:  G Gammon; K Dunn; N Shastri; A Oki; S Wilbur; E E Sercarz
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

2.  Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells.

Authors:  T J Powell; J W Streilein
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

3.  Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses.

Authors:  B Adkins; R Q Du
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

4.  Neonatal tolerance revisited: turning on newborn T cells with dendritic cells.

Authors:  J P Ridge; E J Fuchs; P Matzinger
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

5.  Induction of TH1 and TH2 immunity in neonatal mice.

Authors:  T Forsthuber; H C Yip; P V Lehmann
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

6.  Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.

Authors:  F Mattner; J Magram; J Ferrante; P Launois; K Di Padova; R Behin; M K Gately; J A Louis; G Alber
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

7.  Bone marrow-derived IL-13Rα1-positive thymic progenitors are restricted to the myeloid lineage.

Authors:  Cara L Haymaker; F Betul Guloglu; Jason A Cascio; John C Hardaway; Mermagya Dhakal; Xiaoxiao Wan; Christine M Hoeman; Sarah Zaghouani; Linda M Rowland; Danielle M Tartar; Amie M VanMorlan; Habib Zaghouani
Journal:  J Immunol       Date:  2012-02-20       Impact factor: 5.422

8.  Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.

Authors:  I C Gerling; D V Serreze; S W Christianson; E H Leiter
Journal:  Diabetes       Date:  1992-12       Impact factor: 9.461

9.  Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.

Authors:  Christoph Becker; Stefan Wirtz; Manfred Blessing; Jaana Pirhonen; Dennis Strand; Oliver Bechthold; Julia Frick; Peter R Galle; Ingo Autenrieth; Markus F Neurath
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells.

Authors:  S J Szabo; A S Dighe; U Gubler; K M Murphy
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  9 in total

1.  Neonatal Basophils Stifle the Function of Early-Life Dendritic Cells To Curtail Th1 Immunity in Newborn Mice.

Authors:  Mermagya Dhakal; Mindy M Miller; Adam A Zaghouani; Michael P Sherman; Habib Zaghouani
Journal:  J Immunol       Date:  2015-06-01       Impact factor: 5.422

2.  IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Regulatory T Cell Suppression To Restrain Experimental Allergic Encephalomyelitis.

Authors:  Subhasis Barik; Jason S Ellis; Jason A Cascio; Mindy M Miller; Tobechukwu K Ukah; Alexis N Cattin-Roy; Habib Zaghouani
Journal:  J Immunol       Date:  2017-08-11       Impact factor: 5.422

3.  A New IRF-1-Driven Apoptotic Pathway Triggered by IL-4/IL-13 Kills Neonatal Th1 Cells and Weakens Protection against Viral Infection.

Authors:  Mindy M Miller; Subhasis Barik; Alexis N Cattin-Roy; Tobechukwu K Ukah; Christine M Hoeman; Habib Zaghouani
Journal:  J Immunol       Date:  2019-04-17       Impact factor: 5.422

4.  On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes.

Authors:  Tobechukwu K Ukah; Alexis N Cattin-Roy; Weirong Chen; Mindy M Miller; Subhasis Barik; Habib Zaghouani
Journal:  J Immunol       Date:  2017-06-23       Impact factor: 5.422

5.  The dichotomous pattern of IL-12r and IL-23R expression elucidates the role of IL-12 and IL-23 in inflammation.

Authors:  Gaëlle Chognard; Lisa Bellemare; Adam-Nicolas Pelletier; Maria C Dominguez-Punaro; Claudine Beauchamp; Marie-Josée Guyon; Guy Charron; Nicolas Morin; Durga Sivanesan; Vijay Kuchroo; Ramnik Xavier; Stephen W Michnick; Sylvain Chemtob; John D Rioux; Sylvie Lesage
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 6.  Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma.

Authors:  Katherine H Restori; Bharat T Srinivasa; Brian J Ward; Elizabeth D Fixman
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

7.  Maternal Glucocorticoid Elevation and Associated Fetal Thymocyte Apoptosis are Involved in Immune Disorders of Prenatal Caffeine Exposed Offspring Mice.

Authors:  Han-Xiao Liu; Ting Chen; Xiao Wen; Wen Qu; Sha Liu; Hui-Yi Yan; Li-Fang Hou; Jie Ping
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

Review 8.  Neonatal Immune Responses to Respiratory Viruses.

Authors:  Taylor Eddens; Olivia B Parks; John V Williams
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

9.  CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns.

Authors:  Simon D van Haren; Gabriel K Pedersen; Azad Kumar; Tracy J Ruckwardt; Syed Moin; Ian N Moore; Mahnaz Minai; Mark Liu; Jensen Pak; Francesco Borriello; Simon Doss-Gollin; Elisabeth M S Beijnen; Saima Ahmed; Michaela Helmel; Peter Andersen; Barney S Graham; Hanno Steen; Dennis Christensen; Ofer Levy
Journal:  Nat Commun       Date:  2022-08-02       Impact factor: 17.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.